doi: 10.1007/BF01202435.
[The residue behavior of the furazolidone metabolite 3-(4-cyano-2-oxobutylideneamino)-2-oxazolidone in trout]
[Article in
German]
Affiliations
- PMID: 2293521
- DOI: 10.1007/BF01202435
Item in Clipboard
[The residue behavior of the furazolidone metabolite 3-(4-cyano-2-oxobutylideneamino)-2-oxazolidone in trout]
[Article in
German]
Z Lebensm Unters Forsch.
1990 Oct-Nov.
Abstract
A high-performance liquid chromatography (HPLC)-method for the determination of furazolidone (FZ) and its open-chain cyano-derivative 3-(4-cyano-2-oxobutylideneamino)-2-oxazolidone (M1) in trout is described. Only during the medication period residues of FZ and M1 were detected in the muscle and liver of the trout, which were treated with food containing FZ over a period of 7 days. After the beginning of the withdrawal period, the concentration of FZ and M1 were found to be under the limits of detection.
Similar articles
-
Disposition of 3-(4-cyano-2-oxobutylidene amino)-2-oxazolidone, a cyano-metabolite of furazolidone, in furazolidone-treated grouper.Food Addit Contam. 2003 Mar;20(3):229-36. doi: 10.1080/0265203021000043930. Food Addit Contam. 2003. PMID: 12623646
-
Binding of 14C-furazolidone metabolites to the muscular and hepatic proteins of trout.Food Addit Contam. 1996 Feb-Mar;13(2):199-209. doi: 10.1080/02652039609374398. Food Addit Contam. 1996. PMID: 9064245
-
Fate and microbiological effects of furazolidone in a marine aquaculture sediment.Sci Total Environ. 1991 Oct 15;108(3):275-83. doi: 10.1016/0048-9697(91)90364-k. Sci Total Environ. 1991. PMID: 1754880
-
In vivo and in vitro metabolic studies of furazolidone: a risk evaluation.Drug Metab Rev. 1990;22(6-8):663-76. doi: 10.3109/03602539008991460. Drug Metab Rev. 1990. PMID: 2102448 Review. No abstract available.
-
Development of a unified approach to evaluate the toxicological potential of bound residues.Drug Metab Rev. 1990;22(6-8):891-904. doi: 10.3109/03602539008991477. Drug Metab Rev. 1990. PMID: 2102465 Review. No abstract available.